The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Molecular screening for cancer treatment optimization (MOSCATO 01): A prospective molecular triage trial—Interim results.
Antoine Hollebecque
No relevant relationships to disclose
Christophe Massard
No relevant relationships to disclose
Thierry De Baere
No relevant relationships to disclose
Nathalie Auger
No relevant relationships to disclose
Ludovic Lacroix
No relevant relationships to disclose
Valerie Koubi-Pick
No relevant relationships to disclose
Philippe Vielh
No relevant relationships to disclose
Vladimir Lazar
No relevant relationships to disclose
Rastislav Bahleda
No relevant relationships to disclose
Maud Ngo-camus
No relevant relationships to disclose
Eric Angevin
No relevant relationships to disclose
Andrea Varga
No relevant relationships to disclose
Frederic Deschamps
No relevant relationships to disclose
Anas Gazzah
No relevant relationships to disclose
Clement Mazoyer
No relevant relationships to disclose
Catherine Richon
No relevant relationships to disclose
Gilles Vassal
No relevant relationships to disclose
Alexander M. Eggermont
No relevant relationships to disclose
Fabrice Andre
No relevant relationships to disclose
Jean-Charles Soria
No relevant relationships to disclose